Dr. Dana Joyce Mccreight

DDS | Dentist



  
  502 W Cherokee Ave, Sallisaw
  Oklahoma, 74955-4212

  918-775-3742    Maps & Directions
Dr. Dana Joyce Mccreight is a Sallisaw, Oklahoma based Dentist who is specialized in General Practice Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 502 W Cherokee Ave, Sallisaw. Patients can reach her at 918-775-3742.
Dr. Dana Joyce Mccreight is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Dana Joyce Mccreight speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Dana Joyce Mccreight
Specialization: Dentist
Gender:Female
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:502 W Cherokee Ave, Sallisaw,
Oklahoma, 74955-4212
Phone:918-775-3742
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 7113216664
Enrollment ID: I20160523001526
NPI Number: 1871519751
NPI Enumeration Date: 14 Jul, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 502 W Cherokee Ave,
Sallisaw, Oklahoma
Zip: 74955-4212
Phone Number: 918-775-3742
Patients can reach Dr. Dana Joyce Mccreight at 502 W Cherokee Ave, Sallisaw, Oklahoma or can call to book an appointment on 918-775-3742. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.

Comments/ Reviews: